TSC2 and tuberous sclerosis: Alanine substitutions or tuberous sclerosis-associated mutations of H1640, L1641, or N1643 on TSC2, largely impaired the GAP activity (Fig. 3k, lanes 7–12), to a level comparable to that of lacking TSC complex (Fig. 3k, lane 2).